2007年公司成功研发出电子化合物EDOT合成新路线，成功申请中国专利（CN101220038），并在盐城生产基地建成月产5吨生产线，通过国家ISO9001认证（UQ070125R0）。

        2007 Yield Pharma successfully applied the patent (CN101220038) of synthesizing EDOT in a new route, and established an EDOT assemble line in Yanchen with a monthly capacity of 5MTs. Yield Pharma’s EDOT was confirmed by ISO9001（UQ070125R0）.

        2006-2007年公司成功研发出医药中间体N，N-二甲基磺酰胺（N,N-dimemethylsulfamide）的工业化合成工艺，并在盐城生产基地建成月产1吨生产线，并通过国家ISO9001认证（UQ070125R0）。

        2006-2007 Yieldpharma developed the synthesizing route of N,N-dimemethylsulfamide in mass production and built up a 1MT-monthly-capacity assemble line in Yancheng. Yield Pharma’s N,N-dimemethylsulfamide was confirmed by ISO9001 as well（UQ070125R0）.

        2008年公司成功研发出抗高血压药物波生坦（Bosentan）关键中间体5-(2-甲氧基苯氧基)-[2,2'-二嘧啶]-4,6(1H,5H)-二酮和5-(2-甲氧基苯氧基)-2-(2-嘧啶基)-4,6-二氯嘧啶合成新路线，成功申请中国专利（CN101279984），并在昆山生产基地建成月产2吨生产线。

        2008 After finding a new way to synthesize Bosentan intermediates---- 4,6-Dichloro-5-(2-methoxyphenoxy)[2,2']bipyrimidinyl and  5-(2-methoxyphenoxy)-[2,2'-bipyrimidine]-4,6(1h,5h)-dione, Yield Pharma successfully applied a patent（CN101279984）and built up an assemble line with a monthly capacity of 2MTs in Kunshan.

        2009年公司成功研发出医药中间体环丙磺酰氯(Cyclopropanesulfonyl chloride)和环丙磺酰胺（Cyclopropane sulfonamide）合成新路线，革除了原路线中的超低温反应并在昆山生产基地建成月产1吨生产线。

        2009 By removing the ultra-low temperature reaction, Yield Pharma developed a new route in synthesizing pharmaceutical intermediates---- Cyclopropanesulfonyl chloride and Cyclopropane sulfonamide and built up an assemble line with a monthly capacity of 1MT in Kunshan.

        2009年公司与南京大学签订500个新化合物的服务合同，建立起良好的合作关系。

        2009 Yield Pharma made a contract with Nanjing University about providing 500 new compounds and established a friendly cooperative relationship.